Global Psoriatic Arthritis (PsA) Treatment Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Extent Research has published a new report on the Global Psoriatic Arthritis (PsA) Treatment Market. This report was analyzed by our research analysts with the help of the market experts by keeping in mind to increase the return on the investment. This is done in the Psoriatic Arthritis (PsA) Treatment market report by offering clear and reliable information to the market players and clients that will further assist them in making appropriate decision-making for the business. This information will not just restrict toward established players but new market entrants will also be benefitted and they will be able to identify and examine the market position and competition. The report also offers proper explanation about the supply and demand patterns in several regions, the competitive landscape among the industry players, the challenges that are currently posed in the Psoriatic Arthritis (PsA) Treatment market, the future opportunities that will augment the market growth, and much more.

Data provided by Extent Research. Source: https://www.extentresearch.com/psoriatic-arthritis-psa-treatment-market

In the Psoriatic Arthritis (PsA) Treatment market report the market is segmented based on by Product type Nonsteriodal Anti-inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Biologics, , by Application Hospitals, Clinics, Others, . The market segments will be studied on the basis of market share, revenue, consumption, production, market size, CAGR, and others. Some of the major industry players that are listed in the global Psoriatic Arthritis (PsA) Treatment market report are Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Roche, Bristol-Myers Squibb, Eli Lilly, Amgen, AstraZeneca, Celgene, . The information that is provided for all the market payers are their market share, revenue, sales, recent developments, product portfolio, business strategies, and many other such aspects.

An Overview About the Table of Contents:

Global Psoriatic Arthritis (PsA) Treatment Market Overview
Target Audience for the Psoriatic Arthritis (PsA) Treatment Market
Economic Impact on the Psoriatic Arthritis (PsA) Treatment Market
Global Psoriatic Arthritis (PsA) Treatment Market Forecast
Business Competition by Manufacturers
Production, Revenue (Value) by Region
Production, Revenue (Value), Price Trend by Type
Market Analysis by Application
Cost Analysis
Industrial Chain, Sourcing Strategy, and Downstream Buyers
Marketing Strategy Analysis, Distributors/Traders
Market Effect Factors Analysis

Report Scope and Market Segmentation

ATTRIBUTES	Global Psoriatic Arthritis (PsA) Treatment Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Psoriatic Arthritis (PsA) Treatment Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Nonsteriodal Anti-inflammatory Drugs
        1.2.3 Disease Modifying Antirheumatic Drugs
        1.2.4 Biologics
    1.3 Market by Application
        1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Psoriatic Arthritis (PsA) Treatment Market Perspective (2017-2035)
    2.2 Psoriatic Arthritis (PsA) Treatment Growth Trends by Region
        2.2.1 Psoriatic Arthritis (PsA) Treatment Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2023-2035)
    2.3 Psoriatic Arthritis (PsA) Treatment Market Dynamics
        2.3.1 Psoriatic Arthritis (PsA) Treatment Industry Trends
        2.3.2 Psoriatic Arthritis (PsA) Treatment Market Drivers
        2.3.3 Psoriatic Arthritis (PsA) Treatment Market Challenges
        2.3.4 Psoriatic Arthritis (PsA) Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue
        3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2017-2022)
        3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
    3.4 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio
        3.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2021
    3.5 Psoriatic Arthritis (PsA) Treatment Key Players Head office and Area Served
    3.6 Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
    3.7 Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Type
    4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2023-2035)
5 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Application
    5.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2017-2035)
    6.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type
        6.2.1 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        6.2.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2035)
        6.2.3 North America Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2035)
    6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application
        6.3.1 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        6.3.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2035)
        6.3.3 North America Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2035)
    6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country
        6.4.1 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022)
        6.4.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2017-2035)
    7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type
        7.2.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2035)
        7.2.3 Europe Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2035)
    7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application
        7.3.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2035)
        7.3.3 Europe Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2035)
    7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country
        7.4.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size (2017-2035)
    8.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type
        8.2.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2035)
    8.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application
        8.3.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2035)
    8.4 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region
        8.4.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size (2017-2035)
    9.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type
        9.2.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2035)
        9.2.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2035)
    9.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application
        9.3.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2035)
        9.3.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2035)
    9.4 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country
        9.4.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size (2017-2035)
    10.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type
        10.2.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2035)
    10.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application
        10.3.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2035)
    10.4 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country
        10.4.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction
        11.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Details
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction
        11.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Developments
    11.3 AbbVie
        11.3.1 AbbVie Company Details
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction
        11.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.3.5 AbbVie Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction
        11.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 UCB
        11.5.1 UCB Company Details
        11.5.2 UCB Business Overview
        11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction
        11.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.5.5 UCB Recent Developments
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction
        11.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.6.5 Roche Recent Developments
    11.7 Bristol-Myers Squibb
        11.7.1 Bristol-Myers Squibb Company Details
        11.7.2 Bristol-Myers Squibb Business Overview
        11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction
        11.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.7.5 Bristol-Myers Squibb Recent Developments
    11.8 Eli Lilly
        11.8.1 Eli Lilly Company Details
        11.8.2 Eli Lilly Business Overview
        11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction
        11.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.8.5 Eli Lilly Recent Developments
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction
        11.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.9.5 Amgen Recent Developments
    11.10 AstraZeneca
        11.10.1 AstraZeneca Company Details
        11.10.2 AstraZeneca Business Overview
        11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction
        11.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.10.5 AstraZeneca Recent Developments
    11.11 Celgene
        11.11.1 Celgene Company Details
        11.11.2 Celgene Business Overview
        11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction
        11.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.11.5 Celgene Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Psoriatic Arthritis (PsA) Treatment Market